Clinical Trial Update: Efficacy Study of VA106483 in Males With Nocturia. [Phase 2]

View source ↗

Summary

This Phase 2 efficacy trial evaluated VA106483 for nocturia in men and has completed. No specific efficacy results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• VA106483

Snippet

Sponsor: Vantia Ltd | Conditions: Nocturia | Phase 2 | Status: COMPLETED